ATW Master Fund V LP and Others File Schedule 13G for ENDRA Life Sciences Inc.

ATW Master Fund V LP, ATW Partners Opportunities Management, LLC, Kerry Propper, and Antonio Ruiz-Gimenez have filed a Schedule 13G for ENDRA Life Sciences Inc. The filing indicates that ATW Master Fund V LP holds 116,024 shares of common stock, representing 9.9% of the outstanding shares. The shares are subject to a blocker that prevents the fund from exercising warrants and prefunded warrants to purchase additional shares if it would result in beneficial ownership exceeding 9.99% of the outstanding shares. The filing also includes a joint filing statement pursuant to Rule 13d-1(k)(1), where the parties consent to the joint filing of Schedule 13G and any amendments. The filing is dated October 28, 2025.